Sarah Parsons Pharm.D., BCPPS

Pharmacy Clinical Specialist, Pediatric Infectious Diseases/Antimicrobial Stewardship Co-Lead, mom of boys, fitness lover, and bacteria guru

[Sarah Parsons Pharm.D., BCPPS @SParsonsID]

Excited to present at @ASHPOfficial’s ASHP Advantage virtual symposium on the latest updates in pneumococcal disease and vaccinations. Register and get details: https://t.co/dCRFDChUOb #ASHP25

[Sarah Parsons Pharm.D., BCPPS @SParsonsID]

#NewProfilePic

[Sarah Parsons Pharm.D., BCPPS @SParsonsID]

Charles Mack Ratliff's obituary https://t.co/uLVVZ4Pvh8

[Dr. AK 🇮🇳 @docakx]

Gram positive & Gram negative bacteria

[Sarah Parsons Pharm.D., BCPPS @SParsonsID]

@mmPharmD The worst!

[Sarah Parsons Pharm.D., BCPPS @SParsonsID]

What an amazing conference. Thanks to all my pediatric ID/ASP colleagues for continuing to remind me that I chose the right speciality and inspiring me to be better. #pidsasp24

[IDSA @IDSAInfo]

Ask your House representative to sign a letter in support of authorizing the PASTEUR Act, a bill that would confront the AMR crisis and spur antibiotic development. https://t.co/GhHtu6PAmm

[Contagion @Contagion_Live]

The approval of the antifungal, isavuconazonium sulfate (Cresemba), is indicated for children as young as 1 year of age and the approval was based from 2 clinical trials. @AstellasUS

https://t.co/JElbyDy2u4

[Sarah Parsons Pharm.D., BCPPS @SParsonsID]

Check out our new publication on use of rifabutin and CFTR modulators for MAC in CF.

https://t.co/xovMWsOAuI

[Sarah Parsons Pharm.D., BCPPS @SParsonsID]

Excited to present at @ASHPOfficial’s ASHP Advantage Midyear midday symposium on an update of the pharmacist’s role in current COVID-19 prevention and treatment strategies.
@mmPharmD @yangkath

Register and get details: https://t.co/Xk68jFFM8G #ASHP23

[Monica Mahoney @mmPharmD]

Heading to @ASHPOfficial #ASHP23? Come see us Tuesday at the midday symposia presenting on COVID-19 prevention/treatment updates in immunocompromised patients. @yangkath

Can't be there live? Register for the webinar option! https://t.co/ClZBrOWDmJ

[Timothy Li @drtimothyli]

The more powerful tool isn't always the better choice
It may create collateral damage instead of advantage

Antibiotics are the same

E.g. MSSA
➡️Vancomycin is worse than β-lactams
➡️Even among β-lactams, ceftriaxone is worse than cefazolin or ASP

#WAAW2023

[Sarah Parsons Pharm.D., BCPPS @SParsonsID]

@mmPharmD Honey crisp all the way

[Sarah Parsons Pharm.D., BCPPS @SParsonsID]

NACFC was an amazing experience and I learned so much! Thank you to our program chairs for organizing the session and granting me the opportunity to collaborate with such brilliant co-presenters. ❤️

[Sarah Parsons Pharm.D., BCPPS @SParsonsID]

@mmPharmD Good news is for the east coasters ….most everyone was up! I was shocked the room was at capacity ! This made me so excited / completely terrified…all at once lol. Everyone loves treating NTM

[Sarah Parsons Pharm.D., BCPPS @SParsonsID]

Come say hi. Friday at 7:15…when I present my section ..discussing alternative treatment regimens for the treatment of Mycobacterium avium complex infections in patients receiving concomitant CFTR) modulator therapy.

[Sarah Parsons Pharm.D., BCPPS @SParsonsID]

@JasonMordino Me!

[Sarah Parsons Pharm.D., BCPPS @SParsonsID]

From my neighborhood: https://t.co/GcVhbILykz

[KASIC.MDRO @KASIC_MDRO]

Looking to Cover Confidently? Check out this week’s KASIC pearl to Know your Antibiotic: Ceftazidime’s Coverage Conundrum https://t.co/bwdCDCXMYP #IDtwitter #AntimicrobialResistance #antimicrobialstewardship

[Sarah Parsons Pharm.D., BCPPS @SParsonsID]

@mganio_ASHP @ASHPOfficial You represent us well !!! 💪🏻